Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Board/Management Information 2024

Jan 22, 2024

60507_rns_2024-01-22_a2aa2040-7de0-4891-aeb5-d51ed06d646d.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [100 x 41] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

January 22, 2024

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure − Requirements) Regulations, 2015 Appointment of Mr. Amit Agarwal as Executive Director – Finance & Chief Financial Officer of Pfizer Limited.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that upon recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company at its meeting held today appointed Mr. Amit Agarwal as the Chief Financial Officer of the Company effective February 26, 2024.

Further, upon recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company at its meeting held today, also appointed Mr. Amit Agarwal (DIN: 10465938) as an Additional Director (Whole-time Director) of the Company, designated as Executive Director – Finance & Chief Financial Officer for a period of 5 years with effect from February 26, 2024. The said appointment shall be subject to the approval of shareholders.

Additional details required to be disclosed pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular Nos. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023, and List/Comp/14/2018-19 dated June 20, 2018, are enclosed as Annexure A.

Request you to please take the above on record.

Thanking you,

Yours truly,

For Pfizer Limited PRAJEET Digitally signed by PRAJEET NAIR NAIR Date: 2024.01.22 08:32:22 +05'30' Prajeet Nair

Director – Corporate Services & Company Secretary

CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerltd.co.in

ANNEXURE A

Information as required under Regulation 30 - Part A of Para A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Sr.
no.
Particulars Details
1. Reasons for change Fresh Appointment
2. Date of Appointment and Term Appointed as the Chief Financial Officer of the
Company effective February 26, 2024.
Also
appointed
as
an
Additional
Director
(Whole-time Director), designated as Executive
Director – Finance & Chief Financial Officer effective
February 26, 2024 for a period of 5 (Five) years.
3. Affirmation as per List/Comp/14/
2018-19 dated June 20, 2018
We hereby affirm that Mr. Amit Agarwal is not
debarred or disqualified from holding the office of
Director by virtue of any order from MCA/SEBI or any
other such statutory authority.
4. Relationship
Inter-se
Directors/
Key Managerial Personnel

Mr. Amit Agarwal is not related to any of the
Directors/Key
Managerial
Personnel
of
the
Company.
5. Number of Shares held in the
Company
Nil
6. Brief Profile Mr. Amit Agarwal is a seasoned Finance Professional
and brings with him solid experience of 20 years
across a wide spectrum of Finance functions
including Accounting, Reporting, Audit, Controls,
Strategy and Change management, gained across
diverse industries such as Consumer, Services and
Mining.
Mr. Agarwal joins us from India’s largest consumer
company, Hindustan Unilever Limited, where he
spent the last 17 years serving in various roles
including Accounting, Auditing and controllership as
well as Business Finance roles for different Business
Units including Bakery, Tea, Hair, Deodorants &
Professional Products. In his current assignment at
Hindustan Unilever Limited (HUL), Mr. Agarwal is the
General Manager, Finance, handling the function for
the Sales and Customer Development vertical.
Mr. Agarwal also has a significant experience in
leading global teams. As the Financial Controller for
Global Business Services (GBS), he has led an
End-to-End (E2E) controllership working with a
geographically diverse team across India, UK,
Philippines, and Brazil. Prior to joining HUL, early part
of
Mr.
Agarwal’s
career
was
with
Vedanta
Resources
Limited,
India’s
largest
diversified natural resources company as a Financial
Planning
&
Analysis
Manager
and
Factory
Commercial Manager.
Mr. Amit Agarwal is a Chartered Accountant,
a Cost Accountant and a Company Secretary.
Mr. Agarwal’s stellar academic record mirrors his
solid foundation in financial management and his
strong career trajectory.
Mr. Amit Agarwal does not hold directorship in any
other company.